Gaetano Facchini

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Cristian Lolli, Orazio Caffo, Emanuela Scarpi et al. · Frontiers in Pharmacology · 2016 · 198 citations · Full text

Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients

Alessandro Ottaiano, Renato Franco, Annarita Aiello Talamanca et al. · Clinical Cancer Research · 2006 · 173 citations · Full text

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial

Kim N., Andrew Protheroe, Gaetano Facchini et al. · The Lancet Oncology · 2018 · 163 citations

Patient-reported Outcomes, Urology, Genitourinary Cancer +8

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park et al. · The Lancet Oncology · 2022 · 162 citations · Full text

Urology, Oncology, Metastatic Urothelial Carcinoma +7

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey

Massimiliano Berretta, Chiara Della Pepa, Paolo Tralongo et al. · Oncotarget · 2016 · 144 citations · Full text